טוען...
Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...
שמור ב:
| הוצא לאור ב: | J Neurogastroenterol Motil |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Society of Neurogastroenterology and Motility
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/ https://ncbi.nlm.nih.gov/pubmed/29605979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|